4.2 Meeting Abstract

The efficacy and safety of favipiravir in the treatment of nonsevere COVID-19: a systematic review and meta-analysis of randomized controlled trials

Journal

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
Volume 44, Issue 6, Pages 1491-1491

Publisher

SPRINGER

Keywords

-

Funding

  1. ITM NKFIA [TKP2021-EGA-32]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available